Mark Dybul

2.2k total citations
20 papers, 1.6k citations indexed

About

Mark Dybul is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Mark Dybul has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Virology, 10 papers in Immunology and 7 papers in Infectious Diseases. Recurrent topics in Mark Dybul's work include HIV Research and Treatment (13 papers), Immune Cell Function and Interaction (9 papers) and HIV/AIDS Research and Interventions (4 papers). Mark Dybul is often cited by papers focused on HIV Research and Treatment (13 papers), Immune Cell Function and Interaction (9 papers) and HIV/AIDS Research and Interventions (4 papers). Mark Dybul collaborates with scholars based in United States, Switzerland and United Kingdom. Mark Dybul's co-authors include Anthony S. Fauci, Francesca Celletti, Badara Samb, Justine Hsu, Anna Wright, Jim Yong Kim, Jean‐Paul Moatti, Rifat Atun, Asia Russell and Sania Nishtar and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Mark Dybul

18 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Dybul United States	16	684	596	592	387	327	20	1.6k
John Ayisi Kenya	25	305 0.4×	416 0.7×	219 0.4×	183 0.5×	741 2.3×	38	1.8k
Jimmy Whitworth United Kingdom	24	601 0.9×	1.1k 1.9×	168 0.3×	484 1.3×	161 0.5×	44	1.9k
Stan Houston Canada	24	126 0.2×	620 1.0×	189 0.3×	543 1.4×	122 0.4×	96	1.5k
Bernhard Schwartländer Switzerland	26	384 0.6×	1.5k 2.4×	109 0.2×	997 2.6×	240 0.7×	53	2.4k
Anne Ben‐Smith United Kingdom	22	102 0.1×	782 1.3×	409 0.7×	404 1.0×	194 0.6×	37	1.5k
T. Blake Ball Canada	13	398 0.6×	847 1.4×	274 0.5×	375 1.0×	101 0.3×	26	1.7k
Ephata Kaaya Tanzania	21	169 0.2×	379 0.6×	182 0.3×	516 1.3×	152 0.5×	58	1.7k
Pauli N. Amornkul United States	17	363 0.5×	689 1.2×	90 0.2×	407 1.1×	127 0.4×	24	1.1k
Sizulu Moyo South Africa	20	138 0.2×	1.5k 2.4×	260 0.4×	932 2.4×	97 0.3×	62	2.0k
Mark Dybul United States	22	1.9k 2.8×	2.5k 4.3×	820 1.4×	1.4k 3.7×	184 0.6×	35	3.8k

Countries citing papers authored by Mark Dybul

Since Specialization

Citations

This map shows the geographic impact of Mark Dybul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dybul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dybul more than expected).

Fields of papers citing papers by Mark Dybul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Dybul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dybul. The network helps show where Mark Dybul may publish in the future.

Co-authorship network of co-authors of Mark Dybul

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Dybul. A scholar is included among the top collaborators of Mark Dybul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Dybul. Mark Dybul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rasanathan, Kumanan, Mark Blecher, Mark Dybul, et al.. (2025). Navigating health financing cliffs: a new era in global health. The Lancet. 405(10493). 1893–1895. 4 indexed citations

Huerta‐Yépez, Sara, Simret Beraki, Saleemulla Mahammad, et al.. (2025). Therapeutic Efficacy of CD34-Derived Allogeneic Dendritic Cells Engineered to Express CD93, CD40L, and CXCL13 in Humanized Mouse Models of Pancreatic Cancer. Vaccines. 13(7). 749–749.

Volz, Erik, Nicaise Ndembi, Rebecca G. Nowak, et al.. (2017). Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics. Virus Evolution. 3(2). vex014–vex014. 24 indexed citations

Dybul, Mark. (2017). Health financing seen from the global level: beyond the use of gross national income. Health Economics Policy and Law. 12(2). 117–120. 1 indexed citations

Jay, Jonathan, Kent Buse, David Wilson, et al.. (2016). Building from the HIV Response toward Universal Health Coverage. PLoS Medicine. 13(8). e1002083–e1002083. 11 indexed citations

Piot, Peter, Salim S. Abdool Karim, Robert Hecht, et al.. (2015). Defeating AIDS—advancing global health. The Lancet. 386(9989). 171–218. 183 indexed citations

Samb, Badara, Tim Evans, Mark Dybul, et al.. (2009). An assessment of interactions between global health initiatives and country health systems. The Lancet. 373(9681). 2137–2169. 361 indexed citations

Daucher, Marybeth, David A. Price, Jason M. Brenchley, et al.. (2008). Virological Outcome after Structured Interruption of Antiretroviral Therapy for Human Immunodeficiency Virus Infection Is Associated with the Functional Profile of Virus-Specific CD8⁺T Cells. Journal of Virology. 82(8). 4102–4114. 48 indexed citations

Samb, Badara, Francesca Celletti, Joan Holloway, et al.. (2007). Rapid Expansion of the Health Workforce in Response to the HIV Epidemic. New England Journal of Medicine. 357(24). 2510–2514. 143 indexed citations

10.

Moir, Susan, Angela Malaspina, Oxana K. Pickeral, et al.. (2004). Decreased Survival of B Cells of HIV-viremic Patients Mediated by Altered Expression of Receptors of the TNF Superfamily. The Journal of Experimental Medicine. 200(5). 587–600. 178 indexed citations

11.

Tilton, John C., Alison J. Johnson, Bader Yassine‐Diab, et al.. (2003). Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4⁺T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2. Journal of Virology. 77(20). 10900–10909. 148 indexed citations

12.

Dybul, Mark, Robert Bolan, David Condoluci, et al.. (2002). Evaluation of Initial CD4⁺T Cell Counts in Individuals with Newly Diagnosed Human Immunodeficiency Virus Infection, by Sex and Race, in Urban Settings. The Journal of Infectious Diseases. 185(12). 1818–1821. 60 indexed citations

13.

Dybul, Mark, Bertha Hidalgo, Tae‐Wook Chun, et al.. (2002). Pilot Study of the Effects of Intermittent Interleukin‐2 on Human Immunodeficiency Virus (HIV)–Specific Immune Responses in Patients Treated during Recently Acquired HIV Infection. The Journal of Infectious Diseases. 185(1). 61–8. 68 indexed citations

14.

Malaspina, Angela, Susan Moir, David C. Nickle, et al.. (2002). Human Immunodeficiency Virus Type 1 Bound to B Cells: Relationship to Virus Replicating in CD4⁺T Cells and Circulating in Plasma. Journal of Virology. 76(17). 8855–8863. 30 indexed citations

15.

Chun, Tae‐Wook, J. Shawn Justement, Susan Moir, et al.. (2001). Suppression of HIV replication in the resting CD4⁺T cell reservoir by autologous CD8⁺T cells: Implications for the development of therapeutic strategies. Proceedings of the National Academy of Sciences. 98(1). 253–258. 64 indexed citations

16.

Dybul, Mark, Michael Belson, Claire W. Hallahan, et al.. (2000). CD40 Ligand Trimer and IL-12 Enhance Peripheral Blood Mononuclear Cells and CD4+ T Cell Proliferation and Production of IFN-γ in Response to p24 Antigen in HIV-Infected Individuals: Potential Contribution of Anergy to HIV-Specific Unresponsiveness. The Journal of Immunology. 165(3). 1685–1691. 38 indexed citations

17.

Dybul, Mark, Tae‐Wook Chun, Douglas Ward, et al.. (2000). Evaluation of Lymph Node Virus Burden in Human Immunodeficiency Virus–Infected Patients Receiving Efavirenz‐Based Protease Inhibitor–Sparing Highly Active Antiretroviral Therapy. The Journal of Infectious Diseases. 181(4). 1273–1279. 22 indexed citations

18.

Weissman, Drew, et al.. (2000). Interleukin‐2 Up‐Regulates Expression of the Human Immunodeficiency Virus Fusion Coreceptor CCR5 by CD4⁺Lymphocytes In Vivo. The Journal of Infectious Diseases. 181(3). 933–938. 39 indexed citations

19.

McDyer, John F., Mark Dybul, Theresa J. Goletz, et al.. (1999). Differential Effects of CD40 Ligand/Trimer Stimulation on the Ability of Dendritic Cells to Replicate and Transmit HIV Infection: Evidence for CC-Chemokine-Dependent and -Independent Mechanisms. The Journal of Immunology. 162(6). 3711–3717. 48 indexed citations

20.

Rubbert, A., Christophe Combadière, Mario Ostrowski, et al.. (1998). Dendritic Cells Express Multiple Chemokine Receptors Used as Coreceptors for HIV Entry. The Journal of Immunology. 160(8). 3933–3941. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact